Published • loading... • Updated
What Investors Don't Understand About Abbott Laboratories
Summary by 24/7 Wall St.
1 Articles
1 Articles
What Investors Don't Understand About Abbott Laboratories
The post What Investors Don’t Understand About Abbott Laboratories appeared first on 24/7 Wall St.. Abbott Laboratories (ABT) acquired Exact Sciences for $21B to launch Cancer Diagnostics unit anchored by Cologuard, targeting 50M unscreened Americans. FreeStyle Libre CGM franchise generated $2.08B in Q1; addressable market is 70M-80M patients versus current 10M-12M penetration. This lithium producer surpassed a $1B private valuation, joining …
·Lakewood, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
